Posts Tagged 'uloric'

Gout Medication Subject of FDA Safety Communication

febuxostat prompts fda communicationPatients taking febuxostat (marketed as Uloric) to treat gout will want to pay particular attention to a recent warning issued by the FDA. Last month, the agency released a preliminary alert over concerns that the medication might be responsible for an increased risk of cardiac-related events that could lead to death when compared to an existing medication that could be used as an alternative.

Takeda Pharmaceuticals makes the drug and has been under FDA ...

continue reading...